Everest Medicines (Beijing) Co., Ltd.
Everest Medicines (Beijing) Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients | Squamous Non-Small Cell Lung Cancer sqNSCLC | Not yet recruiting | Phase 1 | 2026-09-11 | NCT07614646 | |
| Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors | Selected Types of Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-08-04 | NCT07095868 |